David Ritchie
Hairy Cell Leukemia
Who We Fund
Since 1949, LLS has provided more than $1.5 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Adam Olszewski
Follicular and marginal zone lymphoma
Catherine Smith
leukemia
Ann-Kathrin Eisfeld
Racial diversity in AML
Timothy Graubert
AML and MDS biology
Thorsten Zenz
Hairy cell leukemia
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Camelia Iancu-Rubin
myeloproliferative neoplasms and immunotherapy
Constellation Pharmaceuticals
myeloproliferative neoplasms
Rong Lu
preleukemia, leukemia
Lev Kats
myeloma and epigenetics
Amin Sobh
Myeloma biology
Daniel Pollyea
AML
Daisuke Nakada
preleukemia, leukemia
Mitchell Geer
leukemia biology
Alex Kentsis
pediatric leukemias
Aditi Shastri
AML, MDS
Mala Shanmugam
myeloma
Kimberly Stegmaier
childhood blood cancers
Stephen Nutt
Myeloma
Venkata Lokesh Battula
immunotherapy and AML
Sattva Neelapu
DLBCL, CAR T
Sami Malek
blood cancer biology
Margaret Shipp
lymphoma biology
John Pimanda
AML, MDS
Jianhua Yu
myeloma immunotherapy
Clara Reglero
pediatric ALL
Daniel Lucas
bone marrow and leukemia biology
G. Greg Wang
DNA biology
Smita Bhatia
pediatric blood cancers, survivorship
Philippe Armand
lymphoma and immunotherapy
Loren Walensky
pediatric leukemia
Sylvain Simon
Immunotherapy, CAR-T safety
Catriona Jamieson
cancer stem cell biology
Ivan Maillard
transplant biology
Alexandra Stevens
childhood AML
Michael Kharas
leukemia
Keisuke Ito
blood cancer stem cells
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Lakshmi Nayak
brain tumors in lymphoma
Matthew Davids
lymphoma therapeutics
Frederick Locke
lymphoma and immunotherapy
Constantine Mitsiades
Waldenström's Macroglobulinemia
Arash Alizadeh
blood cancer biology and diagnosis
Brian Baker
immunotherapy, viral-associated blood cancers
Carl June
CAR T immunotherapy
Jaroslaw Maciejewski
bone marrow failure
Travera
biomarker, myeloma
Ronald Levy
immunotherapies, COVID-19
Dan Vogl
myeloma, microenvironment
Marc Seifert
Hairy cell leukemia
Kevin Shannon
pediatric AML
Alison Moskowitz
lymphoma therapeutics
Zhijian Qian
blood cancer stem cells
Robert Albero Gallego
DNA biology and T-ALL
Grant Challen
preleukemia, leukemia
Baochun Zhang
immunotherapy
Srividya Swaminathan
pediatric, immunotherapy
Joel Pomerantz
diffuse large B-cell lymphoma
Sisi Chen
leukemia
Ryan O'Connell
microRNA and blood cancers
Sameer Parikh
COVID-19
John Leonard
lymphoma research
Shan Lin
preleukemia, leukemia
Selina Chen-Kiang
Mantle cell lymphoma
Patrick Brown
pediatric blood cancers and immunotherapy
Roberta Zappasodi
lymphoma, immunotherapy
Michael Rout
follicular lymphoma, CAR T
Courtney DiNardo
clinical trials, AML
Justin Kline
diffuse large B-cell lymphoma, immunotherapy
Gareth Morgan
smoldering myeloma, MGUS
Sarah Tasian
pediatric leukemias
Robert Signer
cancer stem cell biology
Affimed
immunotherapy, PTCL
Robert Kridel
follicular lymphoma
Nathan Ungerleider
lymphoma biology
Enrico Tiacci
Hairy cell leukemia
Andreas Strasser
cancer cell death
Madhav Dhodapkar
multiple myeloma immunotherapy
Stephen Nimer
myeloid cancer biology
Michael Green
lymphoma biology
Alex Herrera
lymphoma and immunotherapy
NexImmune
immunotherapy, AML, myeloma
Alexey Danilov
lymphoma
Therese Vu
T-All and MLL
Thomas Koehnke
leukemia
Robert Orlowski
(Smoldering) Multiple Myeloma
Johanna Melo-Cardenas
Primary Myelofibrosis
David Weinstock
T-cell lymphoma
Christopher Reilly
leukemia
Wendy Béguelin
follicular lymphoma
Brian Dalton
DNA mutations and myeloid cancers
Jennifer Trowbridge
aging and leukemia
Gongwei Wu
lymphoma biology
Davide Rossi
Hodgkin lymphoma
Caribou Biosciences
immunotherapy, allo-CAR, NHL
Alfred Garfall
myeloma immunotherapy
Hao Jiang
leukemia biology
Ryan Wilcox
T-cell lymphoma
Jianjun Chen
leukemia epigenetics
Michael Keller
COVID-19, immunotherapy
Jaehyuk Choi
T-cell lymphoma
Jolanta Grembecka
leukemia therapeutics
Christiane Querfeld
T-cell lymphoma
Helen Heslop
Immunotherapy
Susan Schwab
cancer immunology
Marcel Spaargaren
Waldenstrom's Macroglobulinemia
Kirsten Williams
leukemia, immunotherapy
Carl Allen
pediatric blood cancers
E. Anders Kolb
pediatric blood cancers
Kathleen Sakamoto
pediatric AML
Balazs Halmos
COVID-19
Jian Xu
leukemia and MPN biology
Liran Shlush
pre-leukemia
Katherine Borden
AML
Santosha Vardhana
COVID-19
Omar Abdel-Wahab
Hairy cell leukemia
Babal Jha
MDS
Carisma Therapeutics
immunotherapy, CAR-macrophage
Daniel Starczynowski
MDS and AML
Kymera Therapeutics
protein degraders, NHL
Andrew Lane
BPDCN
Ravindra Majeti
preleukemia, AML
X4 Pharmaceuticals
Waldenstrom's Macroglobulinemia
Simona Colla
Myeloma biology
George Vassiliou
pre-leukemia
Bruno Paiva
smoldering myeloma
Elvin Wagenblast
Down syndrome-associated leukemia
Charles Mullighan
pediatric ALL
Karin Tarte
follicular lymphoma
Takeshi Egawa
blood cancer biology
Scott Armstrong
pediatric blood cancers
Peng Ji
myeloproliferative neoplasms
Geoffrey Uy
leukemia
Ari Melnick
epigenetics and lymphoma
Caron Jacobson
lymphoma and immunotherapy
Soheil Meshinchi
pediatric AML
Dane Vassiliadis
blood cancer biology
Gianpietro Dotti
CAR T and AML
Michael Savona
MDS and leukemia
Riccardo Dalla-Favera
diffuse large B-cell lymphoma
Ann Mullally
MPN, myelofibrosis
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Abintus Bio
immunotherapy, in vivo CAR, NHL
Robert Bradley
MDS
Rizwan Romee
Immunotherapy
Sean Post
diffuse large B-cell lymphoma
Verastem Oncology
PTCL
Markus Muschen
leukemia and lymphoma biology
Juliette Bouyssou
leukemias and gender
Matteo Bellone
Smoldering multiple myeloma
Larry Kwak
Mantle cell lymphoma, immunotherapy
Dan Landau
cancer evolution biology
Christopher Park
blood cancer stem cells
Saad Usmani
Myeloma
Alec Zhang
myeloma, immunotherapy
Annamaria Gulla
Myeloma
Kerry Rogers
CLL
Jonathan Licht
DNA biology
Piers Patten
COVID-19
Timothy Ley
AML, precision medicine
Iannis Aifantis
leukemia biology and T-ALL
Ryvu Therapeutics
AML, MDS
Jennifer Woyach
CLL trials
Maria "Ken" Figueroa
aging and leukemia
Amer Zeidan
MDS and AML
OncoPep
vaccine, smoldering myeloma
Sutro Biopharma
immunotherapy, NHL, myeloma
Kasey Leger
pediatric blood cancers
Haopeng Yang
follicular lymphoma
Grzegorz Nowakowski
Clinical trial access
Jeffrey Magee
pediatric AML
Craig Jordan
AML
Forty Seven
immunotherapy, MDS, DLBCL
Stephen Oh
myeloproliferative neoplasms
Jason Butler
aging and leukemia
Rajni Kumari
AML
Kura Oncology
MLL leukemia, AML
Chun-Chin Chen
Down syndrome-associated leukemia
Catherine Bollard
pediatric blood cancers and immunotherapy
Ricky Johnstone
epigenetics and lymphoma
Areej El-Jawahri
transplant survivorship
Douglas Hawkins
pediatric blood cancers and immunotherapy
Yan Liu
MDS
Jonas Jutzi
myeloproliferative neoplasms
David Fruman
novel combinations
Eirini Papapetrou
blood cancer stem cells
C. Ola Landgren
myeloma, imaging
Ryotaro Nakamura
ALL, CAR T
Samuel Taylor
leukemia biology
Immunitas Therapeutics
immunotherapy, NHL
Xiangguo Shi
leukemia biology
Terry Fry
CAR T and pediatric AML
Shannon McKinney-Freeman
transplant biology
Tomasz Skorski
myeloproliferative neoplasms, AML
Christina Glytsou
leukemia therapeutics
Brian Walker
smoldering myeloma, MGUS
Jatinder Lamba
pediatric AML, immunotherapy
BioTheryX
protein degraders, AML